Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›SmartTots (Strategies for Mitigating Anesthesia-Related…

U.S. Food and Drug Administration·United States of America

SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership

Rolling / TBD close$500k – $2MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The SmartTots Public-Private Partnership aims to address the critical public health issues associated with the safe use of anesthetic agents and sedatives in young children. The objective of this cooperative agreement is to continue bridging the knowledge gaps, elucidating the risks related to the use of anesthetic and sedative agents in children, and developing strategies for optimizing brain health in children who require anesthesia and sedation care. • The partnership will focus on research and development to improve the safety of anesthetic and sedation agents in children. • The opportunity is open to various types of organizations, including independent school districts, small businesses, public and state-controlled institutions of higher education, and nonprofits. • The award will be in the form of a cooperative agreement. • The project will be funded by the Food and Drug Administration.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Shashi Malhotra(Grants Management Specialist)

[email protected]

(240) 402-7592

Key dates

Opened
5/25/2021
Closes
Rolling / TBD

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
FOR-FD-20-25

Budget estimate

$500,000 – $2,000,000

The budget for this opportunity is not explicitly stated in the document. However, based on the fact that it is a cooperative agreement for research and development, the budget could be in the range of $500,000 to $2 million. This estimate is based on the typical funding amounts for research grants in the healthcare industry. The actual budget could be higher or lower, depending on the specific requirements of the project and the qualifications of the applicant.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 68%

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

Closes 1/27/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

68% match

Limited Competition: BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships

Closes 6/16/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

67% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

State University of New York (SUNY)·New York

67% match

Neurosurgical Products

Closes 11/23/2026Opened 10/30/2026

U.S. Food and Drug Administration·United States of America

67% match

Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

67% match

BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2029Opened 8/28/2025

U.S. Department Of Health And Human Services·District of Columbia

66% match

Brain Repair of Any Injured Neural Structure (BRAINS)

Closes 2/26/2027Opened 7/2/2026

U.S. Department Of Health And Human Services·District of Columbia

66% match

Brain Repair of Any Injured Neural Structure (BRAINS)

Closes 2/26/2027Opened 6/8/2026

U.S. National Institutes of Health·United States of America

66% match

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

Closes 2/20/2029Opened 5/28/2025

U.S. National Institutes of Health·United States of America

66% match

BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)

Closes 6/15/2027Opened 10/23/2024

U.S. National Institutes of Health·United States of America

66% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024

U.S. National Institutes of Health·United States of America

66% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024

U.S. National Institutes of Health·United States of America

66% match

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Closes 1/15/2027Opened 9/18/2024

U.S. National Institutes of Health·United States of America

66% match

BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)

Closes 10/6/2028Opened 5/9/2025

NYS Empire State Development·New York

65% match

NeuroCatalyst Commercialization Fund Administrator

Closes 11/18/2026Opened 10/21/2026

U.S. Department Of Energy·Ohio

65% match

TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform

Closes 12/3/2026Opened 6/4/2026

U.S. National Institutes of Health·United States of America

65% match

Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure ? Clinical Research Sites (U24 Clinical Trial Not Allowed)

Closes 10/31/2027Opened 9/10/2026

State University of New York (SUNY)·New York

65% match

Stryker Neurosurgical Ablation Prod

Closes 11/17/2026Opened 10/26/2026

New York State Energy Research and Development Authority·New York

65% match

Transit Tech Lab Partnership Program

Closes 11/12/2026Opened 10/21/2026

U.S. Department Of Defense·United States of America

65% match

Tolterodine Tartrate ER 24HR Capsules

Closes 12/12/2029Opened 11/21/2022

U.S. Food and Drug Administration·United States of America

65% match

Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

Rolling / TBD closeOpened 11/24/2023

Mental Health, NYS Office of·New York

64% match

Safe Option Support (SOS) Program: CTI Teams

Closes 12/16/2026Opened 10/21/2026

U.S. Department Of Health And Human Services·Maryland

64% match

2 Senior Advisors Services for the NINDS Blueprint Neurotherapeutic Network for Small Molecules External Oversight Committee (EOC) Subject Matter Expert (SME) Services

Closes 11/5/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

64% match

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Closes 8/18/2027Opened 10/1/2024

U.S. Department Of Defense·Maryland

64% match

Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners

Closes 10/18/2028Opened 9/23/2026